Projects per year
Personal profile
Personal Statement
Susan Currie obtained her PhD in Biochemistry (cellular signalling and molecular pharmacology) from the University of Glasgow in 1992 then spent two years at Lilly Research Laboratories, USA, where she studied the role of phospholipase A² in mast cell activation. She returned to the University of Glasgow in 1994 to join the then newly formed Clinical Research Initiative in heart disease and became a founder member of the school of cardiovascular studies in Glasgow. During this time she progressed from postdoctoral researcher to Principal Investigator examining the role of Calcium/calmodulin protein kinase ll (CaMKll) in cardiac hypertrophy and heart failure. She moved to the University of Strathclyde in 2005 as a Lecturer in Physiology & Pharmacology and established an independent cardiovascular signalling research group with principal interests in CaMKll modulation of cardiac calcium handling and cardiac inflammation. She is currently an Associate Professor/Reader within Strathclyde Institute of Pharmacy & Biomedical Sciences and CaMKll as a therapeutic target in cardiac disease remains a key focus of research. More recent research interests include cardiotoxicity in the context of safety pharmacology and devices as well as altered cardiovascular function in ageing and Heart Failure with Preserved Ejection Fraction (HFpEF).
Susan has been research group leader for the Cellular Basis of Disease research group within Strathclyde Institute of Pharmacy & Biomedical Sciences (2021-2023). Externally she was chair of the Scottish Cardiovascular Forum for 12 years (2011-2023). She currently sits on the committee for the British Society of Cardiovascular Research and is an elected Fellow of the Physiological Society. Fellowship was awarded in 2017 in recognition of her contribution to cardiovascular research and the discipline of Physiology. More recently (2024), she has also been elected as a Fellow of the Royal Society of Biology, signifying her international standing in the field of Biological Sciences. She sits on the editorial boards for a range of scientific journals and regularly reviews research funding applications for a number of research councils and charities. She currently teaches on a wide range of classes across both the MPharm and Biomedical Sciences programmes at the University of Strathclyde and coordinates classes on the MPharm programme. She was awarded Fellowship of the Higher Education Academy in 2008.
Susan previously directed the collaborative MPharm programme between the University of Strathclyde and the International Medical University (IMU) in Kuala Lumpur (2012-2017), acting as MPharm representative on the internationalisation committee and was Deputy Director of the MPharm programme at the University of Strathclyde (2012-2018). She is currently Director of Equality, Diversity and Inclusion within Strathclyde Institute of Pharmacy & Biomedical Sciences.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, The regulation of PLA2 activity in mitogen stimulated swiss 3T3 fibroblasts, University of Glasgow
Award Date: 1 Jan 1992
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Investigating the cardiotoxic effects of cobalt on adult human female cardiac fibroblasts
Currie, S. (Principal Investigator)
6/05/25 → 16/06/25
Project: Research - Studentship
-
CULTURE-GAPS in STEM – Collaborative University Learning for Targeting Under-representation in Research and Education – Addressing Attainment GAPS in STEM
Cunningham, M. R. (Principal Investigator), Gibson, L. (CoPI), Wahid, M. (CoPI), Tinto, K. (CoPI) & Currie, S. (CoPI)
1/01/25 → 31/12/25
Project: Internally funded project
-
Cobalt increases oxidation of CaMKII in left ventricular tissue and reduces fibroblast viability and proliferation in female hearts
Cameron Ruiz, M., Callan, R., Sran, A., MacQuaide, N., Pickard, B. & Currie, S., 1 May 2025, In: Heart . 111, S2, p. A6 1 p.Research output: Contribution to journal › Conference abstract › peer-review
Open Access -
Developing an integrated in vivo model of HFpEF in female rats: metabolic stress, cardiac dysfunction and altered excitation-contraction coupling
Olatunji, Z. O., MacKenzie, G., Currie, S. & MacQuaide, N., 1 May 2025, In: Heart . 111, S2, p. A6 1 p.Research output: Contribution to journal › Conference abstract › peer-review
Open Access
Datasets
-
Data for: 'From Freeze to Function: Optimised Cryopreservation and Mitochondrial Analysis Workflow for Skeletal Muscle Biopsies'
Wahid, M. (Creator), MacKenzie, G. (Contributor), Rooney, L. (Contributor), Greig, J. (Contributor), McConnell, G. (Contributor), Combet, E. (Contributor), Gray, S. (Contributor), Murray, J. (Contributor), Currie, S. (Contributor), Gould, G. (Contributor) & Cunningham, M. R. (Creator), University of Strathclyde, 29 Aug 2024
DOI: 10.15129/81f66b7a-4a57-4426-a8ae-fc07e2affc38
Dataset
Prizes
-
Ambassador for British Society of Cardiovascular Research
Currie, S. (Recipient), 2017
Prize: Appointment
-
Elected to Committee of British Society for Cardiovascular Research
Currie, S. (Recipient), 2020
Prize: Election to learned society
Activities
-
48th meeting of EWGCCE
Olatunji, Z. (Participant), Currie, S. (Participant) & MacQuaide, N. (Participant)
1 Jul 2024 → 3 Jul 2024Activity: Participating in or organising an event types › Participation in conference
-
Joint BAS/BSCR meeting at annual BCS conference 2024
Currie, S. (Chair)
3 Jun 2024Activity: Participating in or organising an event types › Participation in conference